Blood coagulation factor XIII: Structure and function

Thrombosis Research

Volumn 94, Issue 5, 1999, Pages 271-305

  Muszbek, László ^a   Yee, Vivien C ^b   Hevessy, Zsuzsa ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Factor XIII; Fibrin; Fibrinogen; Fibrinolysis; Monocytes; Platelets; Pregnancy; Transglutaminase; Wound healing; 2 antiplasmin

Indexed keywords

ANTIPLASMIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 13; FIBRIN; FIBRINOGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

BLOOD CLOTTING; CROSS LINKING; DRUG SYNTHESIS; ENZYME MECHANISM; FIBRINOLYSIS; HUMAN; MONOCYTE; PREGNANCY; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; WOUND HEALING;

EID: 0033152222     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00023-7     Document Type: Review

References (358)

1. Barkan G., Gaspar A. Zur Frage der Reversibilität der Fibringerinnung II. Biochem Ztschr. 139:1923;291-301.
2. Robbins K.C. A study on the conversion of fibrinogen to fibrin. Am J Physiol. 142:1944;581-588.
3. Laki K., Lóránd L. On the solubility of fibrin clots. Science. 108:1948;280.
4. Lóránd L. A study on the solubility of fibrin clots in urea. Acta Physiol Acad Sci Hung. 1:1948;192-196.
5. Lorand L. Fibrin clots. Some properties of the "serum factor" 166(Nature):1950;694-696.
6. Loewy A.G., Veneziale C., Forman M. Purification of the factor involved in formation of urea-insoluble fibrin. Biochim Biophys Acta. 26:1957;670-671.
7. Loewy A.G., Dunathan K., Kriel K., Wolfinger J. Fibrinase I. Purification of substrate and enzyme. J Biol Chem. 236:1961;2625-2633.
8. Loewy A.G., Dahlberg A., Dunathan K., Kriel K., Wolfinger J. Fibrinase II. Some physical properties. J Biol Chem. 236:1961;2634-2643.
9. Loewy A.G., Dunathan K., Gallant J.A., Gardner B. Fibrinase III. Some enzymatic properties. J Biol Chem. 236:1961;2644-2647.
10. Loewy A.G., Gallant J.A., Dunathan K. Fibrinase IV. Effect on fibrin solubility. J Biol Chem. 236:1961;2648-2655.
11. Duckert F., Jung E., Shmerling D.H. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thrombos Diath Haemorrh. 5:1960;179-186.
12. Folk J.A., Finlayson J.S. The epsilon(γ-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem. 31:1977;1-133.
13. Lorand L., Losowsky M.S., Miloszewski K.J.M. Human Factor XIII. Fibrin-stabilizing factor Progr Haemostas Thrombos. 5:1980;245-290.
14. Folk J.E. Mechanism and basis for specificity of transglutaminase catalyzed epsilon(gamma glutamyl) lysine bond formation. Adv Enzymol. 54:1983;1-56.
15. Muszbek L., Laki K. Interaction of thrombin with proteins other than fibrinogen (thrombin susceptible bonds). Activation of factor XIII. Machovich R. The Thrombin. 1984;83-102 CRC Press, Boca Raton.
16. Lorand L. Activation of blood coagulation factor XIII. Ann NY Acad Sci. 485:1986;144-158.
17. McDonagh J. Structure and function of factor XIII. Colman R.W., Hirsh J., Marder V.J., Salzman E.W. Haemostasis and Thrombosis. 1982;164-173 Lippincott, Philadelphia.
18. Miloszewski K.J.A., Losowsky M.S. Fibrin stabilization and factor XIII deficiency. Francis J.L. Fibrinogen, Fibrin Stabilisation and Fibrinolysis. 1988;175-202 Ellis Horwood, Chichester.
19. Bishop P.D., Teller D.C., Smith R.A., Lasser G.W., Gilbert T., Seale R.L. Expression, purification and characterization of human factor XIII in Saccharomyces cerevisiae. Biochemistry. 29:1990;1861-1869.
20. Carrell N.A., Erickson H.P., McDonagh J. Electron microscopy and hydrodynamic properties of factor XIII subunits. J Biol Chem. 264:1989;551-556.
21. Ichinose A., Hendrickson L.E., Fujikawa K., Davie E. Amino acid sequence of the a subunit of human factor XIII. Biochemistry. 25:1986;6900-6906.
22. Ichinose A., McMullen B., Fujikawa K., Davie E. Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments. Biochemistry. 25:1986;4633-4638.
23. Grundmann U., Amann E., Zettlmeissl G., Kupper H.A. Characterization of cDNA coding for human factor XIIIa. Proc Natl Acad Sci USA. 83:1986;8024-8028.
24. Takahashi N., Takahashi Y., Putnam F.W. Primary structure of blood coagulation XIIIa (fibrinoligase, transglutaminase) from human placenta. Proc Natl Acad Sci USA. 83:1986;8019-8023.
25. Ichinose A., Davie E. Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci USA. 85:1988;5829-5833.
26. Board P.G., Webb G.C., McKee J., Ichinose A. Localization of the coagulation factor XIII A-subunit gene (F13A) to chromosome bands 6p24-25. Cytogenet Cell Genet. 48:1988;25-27.
27. Hettasch J.M., Peoples K.A., Greenberg C.S. Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras. J Biol Chem. 272:1997;25149-25156.
28. Korsgren C., Cohen C.M. Organization of the gene for human erythrocyte membrane protein 4.2. Structural similarities with the gene for the a subunit of factor XIII Proc Natl Acad Sci USA. 88:1991;4840-4844.
29. Aeschlimann D., Paulsson M. Transglutaminases. Protein cross-linking reactions in tissues and body fluids Thrombos Haemostas. 71:1994;402-415.
30. Board P.G., Pierce K., Coggan M. Expression of functional coagulation factor XIII in Escherichia coli. Thromb Haemost. 63:1990;235-240.
31. Jagadeeswaran P., Haas P. Synthesis of human coagulation factor XIII in yeast. Gene. 86:1990;279-283.
32. Bröker M., Bäuml O. New expression vectors for the fission yeast Schizosaccharomyces pombe. FEBS Lett. 248:1989;105-110.
33. Hilgenfeld R., Liesum A., Storm R., Metzner H.J., Karges H.E. Crystallization of blood coagulation factor XIII by an automated procedure. FEBS Letts. 265:1990;110-112.
34. Bishop P.D., Lasser G.W., Le Trong I., Stenkamp R.E., Teller D.C. Human recombinant factor XIII from Saccharomyces cerevisiae. Crystallization and preliminary X-ray data. J Biol Chem. 265:1990;13888-13889.
35. Yee V.C., Pedersen L., Le Trong I., Bishop P.D., Stenkamp R.E., Teller D.C. Three-dimensional structure of a transglutaminase. Human blood coagulation factor XIII Proc Natl Acad Sci USA. 91:1994;7296-7300.
36. Kurochkin I.V., Procyk R., Bishop P.D., Yee V.C., Teller D.C., Ingham K.C., Medved L.V. Domain structure, stability and domain-domain interactions in recombinant factor XIII. J Mol Biol. 248:1995;414-430.
37. Aslam S., Poon M.C., Yee V.C., Bowen D.J., Standen G.R. Factor XIIIA Calgary. A candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIIIA subunit Br J Haematol. 91:1995;452-457.
38. Mikkola H., Yee V.C., Syrjala M., Seitz R., Egbring R., Petrini P., Ljung R., Ingerslev J., Teller D.C., Peltonen L., Palotie A. Four novel mutations in deficiency of coagulation factor XIII. Consequences to expression and structure of the A-subunit Blood. 87:1996;141-147.
39. Inbal A., Yee V.C., Kornbrot N., Zivelin A., Brenner B., Seligsohn U. Factor XIII deficiency due to a Leu660Pro mutation in the factor XIII subunit - A gene in three unrelated Palestinian Arab families. Thromb Haemost. 77:1997;1062-1067.
40. Aslam S., Yee V.C., Narayanan S., Duraisamy G., Standen G.R. Structural analysis of a missense mutation (Val414Phe) in the catalytic core domain of the factor XIII(A) subunit. Br J Haematol. 98:1997;346-352.
41. Mikkola H., Muszbek L., Haramura G., Hämäläinen E., Jalanko A., Palotie A. Molecular mechanism of mutations in factor XIII A-subunit deficiency. In vitro expression in COS-cells demonstrates intracellular degradation of the mutant proteins Thromb Haemost. 77:1997;1068-1072.
42. Takahasi N., Tsukamoto H., Umeyama H., Castaman G., Rodeghiero F., Ichinose A. Molecular mechanisms of type II factor XIII deficiency. Novel Gly562-Arg mutation and C-terminal truncation of the A subunit cause factor XIII deficiency as characterized in a mammalian expression system Blood. 91:1998;2830-2838.
43. Ichinose A., Tsukamoto H., Izumi T., Yamazaki T., Togashi M., Takamatsu J., Saito H., Umeyama H. Arg260-Cys mutation in severe factor XIII deficiency. Conformational change of the A subunit is predicted by molecular modelling and mechanics Br J Haematol. 101:1998;264-272.
44. Kangsadalampai S., Chelvanayagam G., Baker R.T., Yenchitsomanus P., Pung-amritt P., Mahasandana C., Board P.G. A novel Asn344 deletion in the core domain of coagulation factor XIII A subunit. Its effects on protein structure and function Blood. 92:1998;481-487.
45. Fox B.A., Yee V.C., Pedersen L.C., Le Trong I., Bishop P.D., Stenkamp R.E., Teller D.C. Identification of the calcium binding site and a novel ytterbium site in blood coagulation factor XIII by X-ray crystallography. J Biol Chem. 274:1999;4917-4923. (In Press).
46. Ichinose A., Bottenus R.E., Davie E.W. Structure of transglutaminases. J Biol Chem. 265:1990;13411-13414.
47. Nonaka M., Matsuda Y., Shiroishi T., Moriwaki K., Nonaka M., Natsuume-Saaki S. Molecular cloning of the b subunit of mouse coagulation factor XIII and assignment of the gene to chromosome 1. Close evolutionary relationship to complement factor H Genomics. 15:1993;535-542.
48. Webb G.C., Coggan M., Ichinose A., Board P.G. Localization of coagulation factor XIII B subunit gene (F13B) to chromosome bands 1q31-32.1 and restriction fragment length polymorphism at the locus. Hum Genet. 81:1989;157-160.
49. Rodriguez de Cordoba S., Rey-Campos S., Dykes D.D., McAlpine P.G., Wong P., Rubinstein P. Coagulation Factor XIIIB subunit is encoded by a gene linked to the regulator of complement activation (RCA) gene cluster in man. Immunogenetics. 28:1988;452-454.
50. Kompf J., Luckenbach C., Kloor D., Krczal D., Amorim A., Ritter H. Linkage analyses of human peptidase C (PEPC), human factor H (HF), and coagulation factor XIIIB (F13B). Hum Genet. 83:1989;97-98.
51. Rey-Campos J., Baeza-Sanz D., Rodriguez de Cordoba S. Physical linkage of the genes coding for complement factor H and coagulation factor XIII B subunit. Genomics. 7:1990;644-646.
52. Griffith L.R., Board P.G., Zwi M.B., Morris B.J., McLeod J.G., Nicholson G.A. The B subunit of coagulation factor XIII is linked to renin, and the Duffy blood group to alpha-spectrin on human chromosome 1. Hum Hered. 39:1989;107-109.
53. Bottenus R., Ichinose A., Davie E. Nucleotide sequence of the gene for the b subunit of human factor XIII. Biochemistry. 29:1990;11195-11209.
54. Patthy L. Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules. Cell. 41:1985;657-663.
55. Patthy L. Detecting homology of distantly related proteins with consensus sequence. J Mol Biol. 198:1987;567-577.
56. Board P.G. Genetic polymorphism of the A subunit of human coagulation factor XIII. Am J Hum Genet. 31:1979;116-124.
57. Board P.G. Genetic polymorphism of the B subunit of human coagulation factor XIII. Am J Hum Genet. 32:1980;348-353.
58. Board P.G., Coggan M. Polymorphism of the A subunit of coagulation factor XIII in the Pacific region. Description of new phenotypes. Hum Genet. 59:1981;135-136.
59. Nishigaki T., Omoto K., Juji T. Genetic polymorphism of the A subunit of human coagulation factor XIII in Japanese. Jap J Hum Genet. 26:1981;237-241.
60. Castle M., Board P.G. An extended survey of the genetic polymorphism at the human coagulation factor XIII A subunit structural locus. Hum Hered. 35:1981;101-106.
61. Sebatan I.M. A new method for FXIIIA genetic variants determination using isoelectric focusing in 1 M urea. Evidence for three structural gene loci, FXIIIA1, FXIIIA2 and FXIIIA3. Hum Genet. 81:1988;95-97.
62. Suzuki K., Matsui K., Ito S., Fujita K., Matsumoto H. Polymorphism of the A subunit of coagulation factor XIII. Evidence for subtypes of the FXIIIA*1 and FXIIIA*2 alleles Am J Hum Genet. 43:1988;170-174.
63. Prata M.J., Amorim A. Formal and population genetics of F13A and FUCA1 polymorphisms in northern Portugal. Hum Hered. 40:1990;45-48.
64. Scacchi R., Corbo R.M., Mulas G., Mureddu L., Pascone R. Genetic polymorphism of the A and B subunits of human coagulation factor XIII in mainland Italy and Sardinia. Description of a new FXIIIA variant allele Electrophoresis. 12:1991;667-670.
65. Anwar R., Stewart A.D., Miloszewski K.J.A., Losowsky M.S. Molecular basis of inherited factor XIII deficiency. Identification of multiple mutations provides insights into protein function Br J Haematol. 91:1995;728-735.
66. Mikkola H., Syrjälä M., Rasi V., Vahtera E., Hämäläinen E., Peltonen L., Palotie A. Deficiency in the A-subunit of coagulation factor XIII. Two novel point mutations demonstrate different effects on transcript levels Blood. 84:1994;517-525.
67. Suzuki K., Henke J., Iwata M., Henke L., Tsuji H., Fukunaga T., Ishimoto G., Szekelyi M., Ito S. Novel polymorphisms and haplotypes in the human coagulation factor XIII A-subunit gene. Hum Genet. 98:1996;393-395.
68. Kohler H.P., Stickland M.H., Ossei-Gerning N., Carter A., Mikkola H., Grant P.J. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost. 79:1998;8-13.
69. McCormack L.J., Kain K., Catto A.J., Kohler H.P., Stickland M.H., Grant P.J. Prevalence of FXIII V34L in populations with different cardiovascular risk. Thromb Haemost. 80:1998;523-524.
70. Nishigaki T., Omoto K. Genetic polymorphism of the B subunit of human coagulation Factor XIII in Japanese. Jap J Hum Gen. 27:1982;265-270.
71. Board P.G. Genetic heterogeneity of the B subunit of coagulation Factor XIII. Resolution of type 2 Ann Hum Genet. 48:1984;223-228.
72. Miller S.A., Dykes D.D., Polesky H.F. Gene frequency distribution of the B subunit of factor XIII (FXIIIB) in Minnesota Whites, Blacks, and Amerindians. Electrophoresis. 6:1985;399-401.
73. Kamboh M.I., Ferrell R.E. Genetic studies of low abundance human plasma proteins. II. Population genetics of coagulation factor XIIIB. Am J Hum Genet. 39:1986;817-825.
74. Dykes D.D., Polesky M.F. The use of the serum protein Factor XIIIB (FXIIIB) in parentage testing. Am J Clin Pathol. 88:1987;627-630.
75. Leifheit H.J., Cleve H. Analysis of the genetic polymorphism of coagulation factor XIIIB (FXIIIB) by isoelectric focusing. Electrophoresis. 9:1988;426-429.
76. Kamboh M.I., Ferrell R.E. Genetic studies of low-abundance human plasma proteins. X. Coagulation factor XIIIB variants in Blacks. Electrophoresis. 10:1989;53-57.
77. Tela M., Scheffran W. Der Faktor 13 B (FSF)-Polymorphismus in schweizerischen Populationen, mit Betrachtungen über europäische Häufigkeitesgradienten. Anthrop Anz. 49:1991;129-136.
78. Nevo S., Cleve H., Koller A., Eigel E., Patutschnick W., Kanaaneh H., Joel A. Serum protein polymorphism in Arab moslems and Druze of Israel. Hum Biol. 64:1992;587-603.
79. Cleve H., Koller A., Patutschnick W., Rodewald A., Nabulsi A. Genetic serum protein polymorphism in Jordanian Arabs. A pilot study of the systems AHSG, BF, F XIII B, GC, PI, PLG and TF Gene Geogr. 6:1992;31-40.
80. Saha N., Tay J.S., Low P.S., Basair J.B. Population genetics of coagulation factor XIIIB in three ethnic groups of Singapore. Ann Hum Biol. 19:1992;277-283.
81. Chen L.Z., Easteal S., Board P.G., Kirk R.L. Genetic affinities of oceanic populations based on RFLP and haplotype analysis of genetic loci on three chromosomes. Hum Biol. 64:1992;1-15.
82. Komatsu N., Kido A., Kimura Y., Oya M., Dobashi Y., Hashimoto K. Polymorphism of coagulation factor XIII B subunit. Further occurrence of FXIIIB*15 in Japanese and phenotyping in bloodstains Int J Legal Med. 104:1992;317-319.
83. Cameselle F.D., Caeiro B., Riveiro A. An alternative modality for the immunodetection of the molecular phenotypes of coagulation factor XIIIB. Hum Hered. 43:1993;257-260.
84. Mizutani K., Nishimukai H., Yasugi T., Iwahashi K., Tsunekawa K., Shinomya T. Polymorphism of serum proteins in Japanese patients with vascular disease. I. Factor XIIIB, plasminogen and complement types in primary varicose veins. Hum Hered. 41:1991;270-275.
85. Board P.G., Chapple R., Coggan M. Haplotypes of the coagulation Factor XIIIA subunit locus in normal and deficient subjects. Am J Hum Genet. 42:1988;712-717.
86. Zoghbi H.Y., Daiger S.P., McCall A., O'Brien W.E., Beaudet A.L. Extensive DNA polymorphism at the Factor XIIIa (F13A) locus and linkage to HLA. Am J Hum Genet. 42:1988;877-883.
87. Board P.G., Losowsky M.S., Miloszewski K.J.A. Factor XIII. Inherited and acquired deficiency Blood Reviews. 7:1993;229-242.
88. Polymeropoulos M.H., Rath D.S., Xiao H., Merril C.R. Tetranucleotide repeat polymorphism at the human coagulation factor XIII A subunit gene (F13A1). Nucl Acid Res. 19:1991;4306.
89. Nishimura D.Y., Murray J.C. A tetranucleotide repeat for the F13B locus. Nucl Acid Res. 20:1992;1167.
90. Radek J.T., Jeong J.M., Wilson J., Lorand L. Association of A subunits of recombinant placental factor XIII with the native carrier B subunits from human plasma. Biochemistry. 32:1993;3527-3534.
91. Yorifuji H., Anderson K., Lynch G.W., Van de Water L., McDonagh J. B protein of factor XIII. Differentiation between free B and complexed B Blood. 72:1988;1645-1650.
92. Krøll J. The subunit composition of factor XIII proteins in normal and factor XIII deficient plasma and serum analysed by line immunoelectrophoresis. Clin Chim Acta. 179:1989;279-284.
93. 2). Thromb Haemost (submitted for publication) 1999.
94. Kangsadalampai S., Board P.G. The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood. 92:1998;2766-2770.
95. Henriksson P., Hedner U., Nilsson I.M., Boehm J., Robertson B., Lorand L. Fibrin-stabilizing factor (Factor XIII) in the fetus and the newborn infant. Pediatr Res. 8:1974;789-791.
96. Greenberg C.S., Shuman M.A. The zymogen form of blood coagulation factor XIII binds specifically to fibrinogen. J Biol Chem. 257:1982;6096-6101.
97. Greenberg C.S., Dobson J.V., Miraglia C.C. Regulation of plasma factor XIII binding to fibrin in vitro. Blood. 66:1985;1028-1034.
98. Credo R.B., Curtis C.G., Lorand L. α-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa). Calcium ion regulatory aspect. Biochemistry. 20:1981;3770-3778.
99. Lorand L., Jeong J.M., Radek J.T., Wilson J. Human plasma factor XIII. Subunit interactions and activation of zymogen Methods Enzymol. 222:1993;22-35.
100. Mary A., Achyuthan K.E., Greenberg C.S. Factor XIII binds to the Aα- and Bβ-chains in the domain of fibrinogen. An immunoblotting study Biochem Biophys Res Commun. 147:1987;608-614.
101. Siebenlist K.R., Meh D.A., Mosesson M.W. Plasma factor XIII binds specifically to fibrinogen molecules containing γ′ chains. Biochemistry. 35:1996;10448-10453.
102. Hornyak T.J., Shafer J.A. Interactions of factor XIII with fibrin as substrate and cofactor. Biochemistry. 31:1992;423-429.
103. Achyuthan K.E., Rowland T.C., Birckbichler P.J., Lee K.N., Bishop P.D., Achyuthan A.M. Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin and fibronectin. Mol Cell Biochem. 162:1996;43-49.
104. Naski M.C., Lorand L., Shafer J.A. Characterization of the kinetic pathway for fibrin promotion of α-thrombin catalyzed activation of plasma factor XIII. Biochemistry. 30:1991;934-941.
105. Buluk K. An unknown function of blood platelets. Pol Tyg Lek. 10:1955;191.
106. Lüscher E.F. Ein fibrinstabilisierender Faktor aus Thrombozyten. Schweiz Med Wochensch. 87:1957;1220-1221.
107. Bohn H. Isolierung und Characterisierung des fibrinstabilisierenden Faktors aus menschlichen Thrombozyten. Thromb Diath Haemorrh. 23:1970;455-468.
108. Kiesselbach T.H., Wagner R.H. Demonstration of factor XIII in human megakaryocytes by a fluorescent antibody technique. Ann NY Acad Sci. 202:1972;318-328.
109. Ádány R., Kiss A., Muszbek L. Factor XIII. A marker of mono- and megakaryocytopoesis Br J Haematol. 67:1987;167-172.
110. Ádány R. Intracellular factor XIII. Cellular distribution of factor XIII subunit a in humans Sem Thromb Hemost. 22:1996;399-408.
111. Lopaciuk S., Lovette K.M., McDonagh J., Chuang H.Y.K., McDonagh R.P. Subcellular distribution of fibrinogen and factor XIII in human blood platelets. Thromb Res. 8:1974;453-465.
112. Broekman M.J., Handin R.J., Cohen P. Distribution of fibrinogen and platelet factor 4 and XIII in subcellular fractions of human platelets. Br J Haematol. 31:1975;51-55.
113. Marx G., Korner G., Mou X., Gorodetsky R. Packaging zinc, fibrinogen and factor XIII in platelet α-granules. J Cell Physiol. 156:1993;437-442.
114. Muszbek L., Ádány R., Szegedi G., Polgár J., Kávai M. Factor XIII of blood coagulation in human monocytes. Thromb Res. 37:1985;401-410.
115. Ádány R., Belkin A., Vasilevskaya T., Muszbek L. Identification of blood coagulation Factor XIII in human peritoneal macrophages. Eur J Cell Biol. 38:1985;171-173.
116. Henriksson P., Becker S., Lynch G., McDonagh J. Identification of intracellular factor XIII in human monocytes and macrophages. J Clin Invest. 76:1985;528-534.
117. Ádány R., Kappelmayer J., Muszbek L. Expression of factor XIII subunit A in different types of human macrophages. Adv Biosci. 66:1987;323-333.
118. Kradin R.L., Lynch G.W., Kurnick J.T., Erikson M., Colvin R.B., McDonagh J. Factor XIII A is synthesized and expressed on the surface of U937 cells and alveolar macrophages. Blood. 69:1987;778-785.
119. Ádány R., Nemes Z., Muszbek L. Characterization of factor XIII containing macrophages in lymph nodes with Hodgkin's disease. Br J Cancer. 55:1987;421-426.
120. Ádány R., Nemes Z., Thomázy V., Muszbek L. Identification of Factor XIII in macrophages invading lymph nodes with Hodgkin's disease. Muszbek L. Haemostasis and Cancer. 1987;125-134 CRC Press, Boca Raton.
121. Turnock K., Bulmer J.N., Gray C. Phenotypic characterization of macrophage subpopulations and localization of factor XIII in the stromal cells of carcinomas. Histochem J. 22:1990;661-666.
122. Nemes Z., Thomázy V., Ádány R., Muszbek L. Identification of histiocytic reticulum cells by the immunohistochemical demonstration of factor XIII (F-XIIIa) in human lymph nodes. J Pathol. 149:1986;121-132.
123. Nemes Z., Ádány R., Thomázy V. Selective visualization of human dendritic reticulum cells in reactive lymphoid follicles by immunohistochemical demonstration of the subunit A of factor XIII (F-XIIIa). Virchows Arch (Cell Pathol). 52:1987;453-466.
124. Ádány R., Muszbek L. Cells containing Factor XIII subunit a in benign and soft tissue tumors. Histopathology. 11:1987;1341-1342.
125. Ádány R., Glukhova M., Kabakov A.Y., Muszbek L. Characterization of connective tissue cells containing factor XIII subunit a. J Clin Pathol. 41:1988;49-56.
126. Estrada J.A., Piérard G.E. Factor XIIIa-positive dendrocytes and the dermal vascular unit. Dermatologica. 180:1990;51-53.
127. Morganroth G.S., Chan L.S., Weinstein G.D., Voorhes J.J., Cooper K.D. Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells and FXIIIa+ perivascular dendritic cells. J Invest Dermatol. 96:1991;333-340.
128. Nemes Z. Differentiation markers in hemangiopericytoma. Cancer. 69:1992;133-140.
129. Cerio R., Griffiths C.E., Cooper K.D., Nickoloff B.J., Headington J.T. Characterisation of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol. 121:1989;421-431.
130. + cells in developing human skin. Anat Embriol. 193:1996;35-41.
131. Nurminskaya M., Magee C., Nurminsky D., Linsenmayer T.F. Plasma transglutaminase in hypertrophic chondrocytes. Expression and cell-specific intracellular activation produce cell death and externalization J Cell Biol. 142:1998;1135-1144.
132. Weisberg L.J., Shiu D.T., Conkling P.R., Shuman M.A. Identification of normal human peripheral blood monocytes and liver as sites of synthesis of coagulation factor XIII a-chain. Blood. 70:1987;579-582.
133. Ádány R., Antal M. Three different cell types can synthesize factor XIII subunit A in the human liver. Thromb Haemost. 76:1996;74-79.
134. Bohn H., Schwick H.G. Isolierung and Characterisierung eines fibrinstabilierenden Faktors aus menschlichen Plazenten. Arzneim Forsch. 21:1971;1432-1439.
135. Chung S.I. Comparative studies on tissue transglutaminase and factor XIII. Ann NY Acad Sci. 202:1972;240-255.
136. Kappelmayer J., Bacskó G., Kelemen E., Ádány R. Onset and distribution of FXIII-containing cells in the mesenchyme of chorionic villi during early phase of human placentation. Placenta. 15:1994;613-623.
137. Ádány R., Muszbek L. Immunohistochemical detection of Factor XIII subunit a in hystiocytes of human uterus. Histochemistry. 91:1989;169-174.
138. Fear J.D., Jackson P., Gray C., Miloszewski K.J.A., Losowsky M.S. Localization of factor XIII in human tissues using an immunoperoxidase technique. J Clin Pathol. 37:1984;560-563.
139. Reid M.B., Gray C., Fear J.D., Bird C.C. Immunohistochemical demonstration of factors FXIIIa and XIIIs in reactive and neoplastic fibroblastic and fibrohistiocytic lesions. Histopathology. 10:1986;1171-1178.
140. Nemeth A.J., Penneys N.S. Factor XIIIa is expressed by fibroblasts in fibrovascular tumors. J Cutan Pathol. 16:1989;266-271.
141. Ádány R. Identification of Factor XIIIa in cutaneous tissue. Reply. Histopathology. 13:1988;363-364.
142. Walls W.D., Losowsky M.S. Plasma fibrin stabilizing factor (FSF) activity in normal subjects and patients with chronic liver disease. Thromb Diath Haemorrh. 21:1969;134-143.
143. Biland L., Duckert F., Prisender S., Nyman D. Quantitative estimation of coagulation factors in liver disease. The diagnostic and prognostic value of factor XIII, factor V and plasminogen. Thromb Haemost. 39:1979;646-656.
144. Gybryelewicz A., Bielawiec M. Fibrin stabilization, factor XIII transamidase activity and subunits "a" and "b" concentration in plasma of patients with liver cirrhosis. Folia Haematol. 113:1986;539-544.
145. Yoshioka K., Miyata H., Uraoka Y., Maki S. Plasma factor XIII levels in children with renal disease. Nephron. 27:1981;19-24.
146. Cucuianu M.P., Miloszewski K., Porutiu D., Losowsky M.S. Plasma factor XIII and platelet factor XIII in hyperlipaemia. Thromb Haemost. 36:1976;542-550.
147. Ikematsu S. An approach to the metabolism of factor XIII. Acta Haematol Jpn. 44:1981;1499-1505.
148. Miloszewski K.J.A., Losowsky M.S. Clinical consequences of inherited and acquired factor XIII deficiency. Egbring R., Klingemann H.D. Factor XIII and fibronectin - New clinical and biological approaches. 1983;31-39 Die Medizinische Verlagsgesellschaft mbH, Marburg/Lahn.
149. Trimble C.L., Gray M.H., McNutt N.S. The distribution of factor XIIIa-positive cells in the human fetus and placenta. Virchows Archiv A Pathol Anat. 420:1992;513-518.
150. Derrick E.K., Barker J.N., Khan A., Price M.L., McDonald D.M. The tissue distribution of factor XIIIa positive cells. Histopathology. 22:1993;157-162.
151. Nagy J.A., Henriksson P., McDonagh J. Biosynthesis of factor XIII B subunit by human hepatoma cell lines. Blood. 68:1986;1272-1279.
152. Wölpl A., Lattke H., Board P.G., Arnold A., Schmeiser T., Kubanek B., Robin-Winn M., Pichelmayr R., Goldmann S.F. Coagulation factor XIII A and B subunits in bone marrow and liver transplantation. Transplantation. 43:1987;151-153.
153. Poon M.C., Russel J.A., Low S., Sinclair G.D., Jones A.R., Blahey W., Ruether B.A., Hoar D.I. Hemopoietic origin of factor XIII subunits in platelets, monocytes and plasma. Evidence from bone marrow transplantation studies. J Clin Invest. 84:1989;787-792.
154. Hashiguchi T., Ichinose A. Molecular and cellular basis of deficiency of the b subunit for factor XIII secondary to a Cys430-Phe mutation in the seventh Sushi domain. J Clin Invest. 95:1995;1002-1008.
155. Kaetsu H., Hashiguchi T., Foster D., Ichinose A. Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells. J Biochem. 119:1996;961-969.
156. Yee V.C., Pedersen L.C., Bishop P.D., Stenkamp R.E., Teller D.C. Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII. Thromb Res. 78:1995;389-397.
157. Hornyak T.J., Bishop P.D., Shafer J.A. α-thrombin-catalyzed activation of human platelet factor XIII. Relationship between proteolysis and factor XIIIa activity Biochemistry. 28:1989;7326-7332.
158. Janus T.J., Lewis S.D., Lorand L., Shafer J.A. A promotion of thrombin-catalyzed activation of factor XIII by fibrinogen. Biochemistry. 22:1983;6269-6272.
159. Lewis S.D., Janus T.J., Lorand L., Shafer J.A. Regulation of formation of factor XIIIa by its fibrin substrates. Biochemistry. 24:1985;6772-6777.
160. Greenberg C.S., Miraglia C.C. The effect of fibrin polymers on thrombin catalyzed plasma factor XIII formation. Blood. 66:1985;466-469.
161. Greenberg C.S., Miraglia C.C., Rickles F.R., Shuman M.A. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. Arch Biochem Biophys. 262:1988;142-148.
162. Greenberg C.S., Achyuthan K.E., Rajagopalan S., Pizzo S.V. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII. J Clin Invest. 75:1985;1463-1470.
163. Greenberg C.S., Achyuthan K.E., Fenton J.W. Factor XIIIa formation promoted by complexing of α-thrombin, fibrin and plasma factor XIII. Blood. 69:1987;867-871.
164. Polgár J., Léránt I., Muszbek L., Machovich R. Thrombomodulin inhibits the activation of factor XIII by thrombin. Thromb Res. 43:1986;585-590.
165. 2+-related regulatory function of fibrinogen. Proc Natl Acad Sci USA. 75:1978;675-682.
166. Mary A., Achyuthan K.E., Greenberg C.S. b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII. Biochim Biophys Acta. 966:1988;328-335.
167. Curtis C.G., Brown K.L., Credo R.B., Domanik R.A., Gray P., Stenberg P., Lorand L. Calcium-dependent unmasking of active center cystein during activation of fibrin stabilizing factor. Biochemistry. 13:1974;3774-3780.
168. Greenberg C.S., Enghild J.J., Mary A., Dobson J.V., Achyuthan K.E. Isolation of a fibrin-binding fragment from blood coagulation factor XIII capable of crosslinking fibrin(ogen). Biochem J. 256:1988;1013-1019.
169. Hornyak T.J., Shafer J.A. Role of calcium ion in the generation of factor XIII activity. Biochemistry. 30:1991;6175-6182.
170. Cook R.D. Calcium-induced dissociation of human plasma factor XIII and the appearance of catalytic activity. Biochem J. 141:1974;683-691.
171. Chung S.I., Lewis M.S., Folk J.E. Relationship of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structure. J Biol Chem. 249:1974;940-950.
172. Seelig G.F., Folk J.E. Half-of-the-sites and all-of-the-sites reactivity in human plasma blood coagulation factor XIIIa. J Biol Chem. 255:1980;9589-9593.
173. De Backer-Royer C., Traoré F., Meunier J.C. Purification and properties of factor XIII from human placenta. Int J Biochem. 24:1992;91-97.
174. Lorand L., Credo R.B., Janus T.J. Factor XIII (fibrin stabilizing factor). Meth Enzymol. 80:1981;333-341.
175. Polgár J., Hidasi V., Muszbek L. Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII). Biochem J. 267:1990;557-560.
176. Muszbek L., Haramura G., Polgár J. Transformation of cellular factor XIII into an active zymogen transglutaminase in thrombin-stimulated platelets. Thromb Haemost. 74:1995;702-705.
177. Muszbek L., Polgár J., Boda Z. Platelet factor XIII becomes active without the release of activation peptide during platelet activation. Thromb Haemost. 69:1993;282-285.
178. 2+ dependent crosslinking process in human platelets. Biochim Biophys Acta. 676:1981;137-147.
179. Hársfalvi J., Fésüs L., Tarcsa E., Laczko J., Loewy A.G. The presence of a covalent crosslinked matrix in human platelets. Biochim Biophys Acta. 1073:1991;268-274.
180. Ando Y., Imamura S., Yamagata Y., Kitahara A., Saji H., Murachi T., Kannagi R. Platelet factor XIII is activated by calpain. Biochem Biophys Res Commun. 144:1987;484-490.
181. Lorand L., Conrad S.M. Transglutaminases. Mol Cell Biochem. 58:1984;9-35.
182. Micanovic R., Procyk R., Lin W., Matsueda G.R. Role of histidine 373 in the catalytic activity of coagulation factor XIII. J Biol Chem. 269:1994;9190-9194.
183. Pedersen L.C., Yee V.C., Bishop P.D., Le Tong I., Teller D.C., Stenkamp R.E. Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules. Protein Sci. 3:1994;1131-1135.
184. Achyuthan K.E., Mary A., Greenberg C.S. Tb(III)-ion-binding-induced conformational changes in platelet Factor XIII. Biochem J. 257:1989;331-338.
185. Weiss M.S., Metzner H.J., Hilgenfeld R. Two non-proline cis peptide bonds may be important for factor XIII function. FEBS Lett. 423:1998;291-296.
186. Catani M.V., Bernassola F., Rossi A., Melino G. Inhibition of clotting factor XIII activity by nitric oxide. Biochem Biophys Res Commun. 249:1998;275-278.
187. Guerrero Guerrero B.A., Arocha-Piñango C.L., Gil San Juan A. Lonomia Achelous caterpillar venom (LACV) selectively inactivates blood clotting factor XIII. Thromb Res. 87:1997;83-93.
188. Guerrero Guerrero B.A., Arocha-Piñango C.L., Gil San Juan A. Degradation of human factor XIII by Lonomin V, a purified fraction of Lonomia Achelous caterpillar venom. Thromb Res. 87:1997;171-181.
189. Gorman J.J., Folk J.E. Structural features of glutamine substrates for transglutaminases. Specificities of human plasma factor XIIIa and the guinea pig liver enzyme J Biol Chem. 256:1981;2712-2715.
190. Gorman J.J., Folk J.E. Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and the guinea pig liver enzyme J Biol Chem. 259:1984;9007-9010.
191. Parameswaran K.N., Velasco P.T., Wilson J., Lorand L. Labeling of ε-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase. Proc Natl Acad Sci USA. 87:1990;8472-8475.
192. Shafer J.A., Higgins D.L. Human fibrinogen. CRC Crit Rev Clin Lab Sci. 26:1988;1-41.
193. Mosesson M.W. The assembly and structure of the fibrin clot. Nouv Rev Fr Hematol. 34:1992;11-16.
194. Blombäck B. Fibrinogen and fibrin - Proteins with complex roles in hemostasis and thrombosis. Thromb Res. 83:1996;1-75.
195. Mosesson M.W. Fibrinogen and fibrin polymerization. Appraisal of the binding events that accompany fibrin generation and fibrin clot assembly Blood Coag Fibrinolysis. 8:1997;257-267.
196. Weisel J.W., Francis C.W., Nagaswami C., Marder V.J. Determination of the topology of factor XIIIa-induced fibrin γ-chain cross-links by electron microscopy of ligated fragments. J Biol Chem. 268:1993;26618-26624.
197. Siebenlist K.R., Meh D.A., Wall J.S., Hainfeld J.F., Mosesson M.W. Orientation of the carboxy-terminal regions of fibrin γ-chain dimers determined from the crosslinked products formed in the mixtures of fibrin, fragment D and factor XIIIa. Thromb Haemost. 74:1995;1113-1119.
198. Mosesson M.W., Siebenblist K.R., Amrani D.L., DiOrio J.P. Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin*. Proc Natl Acad Sci USA. 86:1989;1113-1117.
199. Siebenlist K.R., Mosesson M.W. Factors affecting γ-chain multimer formation in cross-linked fibrin. Biochemistry. 31:1992;936-941.
200. Shainoff J.R., Urbanic D.A., DiBello P.M. Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. J Biol Chem. 266:1991;6429-6437.
201. Grøn B., Filion-Myklebust C., Bennick A., Nieuwenhuizen W., Matsueda G.R., Brosstad F. Early cross-linked fibrin in human plasma contains α-polymers with intact fibrinopeptide A. Blood Coag Fibrinolysis. 3:1992;731-736.
202. Lorand L., Ong H.H. Labeling of amine-acceptor cross-linking sites of fibrin by transpeptidation. Biochemistry. 5:1966;1747-1753.
203. Lorand L. Physiological crosslinking of fibrin. Thromb Diath Haemorrh. 39(Suppl):1970;75-102.
204. Ly B., Kierulf P., Jakobsen E. Stabilization of soluble fibrin/fibrinogen complexes by fibrin stabilizing factor (FSF). Thromb Res. 4:1974;509-522.
205. Kanaide D., Shainoff J.R. Cross-linking of fibrinogen and fibrin by fibrin-stabilizing factor (factor XIIIa). J Lab Clin Med. 85:1975;574-597.
206. Blombäck B., Procyk R., Adamson L., Hessel B. FXIII induced gelation of human fibrinogen - An alternative thiol enhanced, thrombin independent pathway. Thromb Res. 37:1985;613-628.
207. Blombäck B., Banerjee D., Carlsson K., Hamsten A., Hessel B., Procyk R., Silveira A., Zacharski L. Native fibrin gel networks and factors influencing their formation in health and disease. Liu C.Y., Chien S. Fibrinogen, Thrombosis, Coagulation and Fibrinolysis. 1990;1-23 Plenum Press, New York.
208. Fowler W.E., Erickson H.P., Hantgan R.R., McDonagh J., Hermans J. Cross-linked fibrinogen dimer demonstrate a feature of the molecular packing in fibrin fibers. Science. 211:1981;287-289.
209. Dardik B.N., Shainoff J.R. Crosslinking of monomeric fibrin by factor XIIIa. Thrombos Haemostas. 42:1979;864-872.
210. Dyr J.E., Blombäck B., Hessel B., Kornalík F. Conversion of fibrinogen to fibrin by preferential release of fibrinopeptide B. Biochim Biophys Acta. 990:1989;18-24.
211. Francis R.T., McDonagh J., Mann K.G. Factor V is a substrate for the transamidase factor XIIIa. J Biol Chem. 261:1986;9787-9792.
212. Wang D.L., Annamalai A.E., Ghosh S., Gewirtz A.M., Colman R.W. Human platelet factor V is crosslinked to actin by FXIIIa during platelet activation by thrombin. Thromb Res. 57:1990;39-57.
213. Huh M.M., Schick B., Schick P.K., Colman R.W. Covalent crosslinking of human coagulation factor V by activated factor XIII from guinea pig megakaryocytes and human plasma. Blood. 71:1988;1693-1702.
214. Aoki N., Harpel P.L. Inhibitors of the fibrinolytic enzyme system. Sem Thromb Haemostas. 10:1984;24-41.
215. 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest. 65:1980;290-297.
216. 2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor. Biochim Biophys Acta. 661:1981;280-286.
217. 2-plasmin inhibitor to fibrinogen by fibrin-stabilizing factor. Biochim Biophys Acta. 706:1982;158-164.
218. 2-antiplasmin is a substrate of transglutaminase C. Its significance in the regulation of fibrinolysis. Thromb Haemost. (Suppl):1997;33a.
219. 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Biol Chem. 257:1982;14767-14772.
220. 2-plasmininhibitor. J Biol Chem. 261:1986;15591-15595.
221. 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. J Clin Invest. 77:1986;1006-1013.
222. 2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII. Thromb Res. 33:1984;419-425.
223. 2-plasmin inhibitor. J Biochem. 106:1989;703-707.
224. 2-plasmin inhibitor in human plasma. Biochem J. 291:1993;623-625.
225. Jansen P.H., Lorand L., Ebbesen P., Gliemann J. Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Eur J Biochem. 214:1993;141-146.
226. Bendixen E., Borth W., Harpel P.C. Transglutaminases catalyze cross-linking of plasminogen to fibronectin and human endothelial cells. J Biol Chem. 268:1993;21962-21967.
227. Bendixen E., Harpel P.C., Sottrup-Jensen L. Location of the major epsilon-(gamma-glutamyl)lysyl cross-linking site in transglutaminase modified human plasminogen. J Biol Chem. 270:1995;17929-17933.
228. Borth W., Chang V., Bishop P., Harpel P.C. Lipoprotein (a) is a substrate for FXIIIa and tissue transglutaminase. J Biol Chem. 266:1991;18149-18153.
229. Romanic A.M., Arleth A.J., Wilette R.N., Ohlstein E.H. Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions. Circ Res. 83:1998;264-269.
230. Mosher D.F. Cross-linking of cold-insoluble globulin by fibrin stabilizing factor. J Biol Chem. 250:1975;6614-6621.
231. Williams E.C., Janmey P.A., Johnson R.B., Mosher D.F. Fibronectin. Effect of disulfide bond reaction on its physical and functional properties. J Biol Chem. 258:1983;6595-6601.
232. Okada M., Blombäck B., Chang M.D., Horowitz B. Fibronectin and fibrin gel structure. J Biol Chem. 260:1985;1811-1820.
233. Mosher D.F., Johnson R.B. Specificity of fibronectin-fibrin cross-linking. Ann NY Acad Sci. 408:1983;583-594.
234. McDonagh R.P., McDonagh J., Petersen T.E., Thøgersen H.C., Skorstengaard K., Sottrup-Jensen L., Magnusson S., Dell A., Morris H.R. Amino acid sequence of the factor XIIIa acceptor site in bovine plasma fibronectin. FEBS Letts. 127:1981;174-178.
235. Fésüs L., Mestis M.L., Muszbek L., Koteliansky V.E. Transglutaminase-sensitive glutamine residues of human plasma fibronectin revealed by studying its proteolytic fragments. Eur J Biochem. 154:1986;371-374.
236. Procyk R., Adamson L., Block M., Blombäck B. Factor XIII catalyzed formation of fibrinogen-fibronectin oligomers - A thiol enhanced process. Thromb Res. 40:1985;833-852.
237. Procyk R., Blombäck B. Factor XIII-induced crosslinking in solutions of fibrinogen and fibronectin. Biochim Biophys Acta. 967:1988;304-313.
238. Mosher D.F., Schad P.E., Kleinman H.K. Cross-linking of fibronectin to collagen by blood coagulation factor XIIIa. J Clin Invest. 64:1979;781-787.
239. Barry E.L.R., Mosher F.D. Factor XIII cross-linking of fibronectin at cellular matrix assembly sites. J Biol Chem. 263:1988;10464-10469.
240. Barry E.L.R., Mosher F.D. FXIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. Cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments. J Biol Chem. 264:1989;4179-4185.
241. Keski-Oja J., Mosher D.F., Vaheri A. Crosslinking of major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII. Cell. 9:1976;29-35.
242. Sane D.C., Moser T.L., Pippen A.M.M., Parker C.J., Achyuthan K.E., Greenberg C.S. Vitronectin is a substrate for transglutaminases. Biochem Biophys Res Commun. 157:1988;115-120.
243. Skorstengaard K., Halkier T., Højrup P., Mosher D. Sequence location of a putative transglutaminase cross-linking site in human vitronectin. FEBS Letts. 262:1990;269-274.
244. Prince C.W., Dickie D., Krumdieck C.L. Osteopontin, a substrate for transglutaminase and factor XIII activity. Biochem Biophys Res Commun. 177:1991;1205-1210.
245. Martin M.T., Lefebvre F., Rabaud M., Graves P.V. Biochemical study of adduct synthesis between fibrin monomers and elastin. Biomaterials. 9:1988;519-524.
246. Hada M., Kaminski M., Bockenstedt P., McDonagh J. Covalent crosslinking of von Willebrand factor to fibrin. Blood. 68:1986;95-101.
247. Bockenstedt P., McDonagh J., Handin R.I. Binding and covalent crosslinking of purified von Willebrand factor to native monomeric collagen. J Clin Invest. 78:1986;551-556.
248. Bale M.D., Westrick L.G., Mosher D.F. Incorporation of thrombospondin into fibrin clots. J Biol Chem. 260:1985;7502-7508.
249. Bale M.D., Mosher D.F. Thrombospondin is a substrate for blood coagulation factor XIIIa. Biochemistry. 25:1986;5667-5673.
250. Lynch G.W., Slayter H.S., Miller B.E., McDonagh J. Characterization of thrombospondin as a substrate for factor XIII transglutaminase. J Biol Chem. 262:1987;1772-1778.
251. Cohen I., Young-Bandala L., Blankenberg T.A., Siefring G.E., Bruner-Lorand J. Fibrinoligase-catalyzed cross-linking of myosin from platelet and skeletal muscle. Arch Biochem Biophys. 192:1979;100-111.
252. Cohen I., Blankenberg T.A., Borden D., Kahn D.R., Veis A. Factor XIIIa-catalyzed cross-linking of platelet and muscle actin. Regulation by nucleotides. Biochim Biophys Acta. 628:1980;365-375.
253. Horváth A.R., Asijee G.M., Muszbek L. Cytoskeletal assembly and vinculin-cytoskeleton interaction in different phases of the activation of bovine platelets. Cell Motil Cytoskeleton. 21:1992;123-131.
254. Asijee G.M., Muszbek L., Kappelmayer J., Polgár J., Horváth A., Sturk G. Platelet vinculin. a substrate of activated factor XIII Biochim Biophys Acta. 954:1988;303-308.
255. Mellanby J., Pratt C.L.G. Calcium and blood coagulation. Proc Roy Soc B. 128:1939;201-213.
256. Hartert H. Rheo-stimulation. A new method for the assay of clotting process and factor XIII. A preliminary report Biorheology. 11:1974;355-360.
257. Shen L.L., Hermans J., McDonagh J., McDonagh R.P., Carr M. Effects of calcium ions and covalent crosslinking on formation and elasticity of fibrin gels. Thromb Res. 6:1975;255-265.
258. Gelman R.A., Gladner J.A., Nossal R. Rigidity of fibrin gels as measured by quasielastic light scattering. Biopolymers. 19:1980;1259-1270.
259. Shen L.L., Lorand L. Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with purified zymogen. J Clin Invest. 71:1983;1336-1341.
260. Gladner J.A., Nossel R. Effects of crosslinking on the rigidity and proteolytic susceptibility of human fibrin clots. Thromb Res. 30:1983;273-288.
261. Kamykowski G.W., Mosher D.F., Lorand L., Ferry J.D. Modification of shear modulus and creep compliance of fibrin clots by fibronectin. Biophys Chem. 13:1981;25-28.
262. Chou T.W., McIntire L.W., Petersen D.M. Importance of plasma fibronectin in determining PFP and PRP clot mechanical properties. Thromb Res. 29:1983;243-248.
263. Carr M.E., Gabriel D.A., McDonagh J. Influence of factor XIII and fibronectin on fiber size and density in thrombin-induced fibrin gels. J Lab Clin Med. 110:1987;747-752.
264. Lorand L., Jacobsen A. Accelerated lysis of blood clots. Nature. 195:1962;911-912.
265. Gormsen J., Fletcher A.P., Alkjaersig N., Sherry S. Enzymatic lysis of plasma clots. The influence of fibrin stabilization on lysis rates Arch Biochem Biophys. 120:1967;654-665.
266. Henderson K.W., Nussbaum M. The mechanism of enhanced streptokinase induced clot lysis following in-vitro factor XIII inactivations. Br J Haemat. 17:1969;445-453.
267. McDonagh R.P., McDonagh J., Duckert F. The influence of fibrin crosslinking on the kinetics of urokinase-induced clot lysis. Br J Haematol. 21:1971;323-332.
268. Schwartz M.L., Pizzo S.V., Hill R.I., McKee P.A. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. J Clin Invest. 50:1971;1506-1513.
269. Gaffney P.J., Whitaker A.N. Fibrin crosslinks and lysis rates. Thromb Res. 14:1979;85-94.
270. Jansen J.W.C.M., Haverkate F., Koopman J., Nieuwenhuis H.K., Kluft C., Boschman T.A.C. Influence of factor XIIIa activity on human whole blood clot lysis in vitro. Thrombos Haemostas. 57:1987;171-175.
271. Leidy E.M., Stern A.M., Friedman P.A., Bush L.R. Enhanced thrombolysis by a factor XIIIa inhibitor in a rabbit model of femoral artery thrombosis. Thromb Res. 59:1990;15-26.
272. Shebuski R.J., Sitko G.R., Claremon D.A., Baldwin J.J., Remy D.C., Stern A.M. Inhibition of factor XIIIa in a canine model of coronary thrombosis. Effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activator Blood. 75:1990;1455-1459.
273. Haverkate F. Lysis of crosslinked and non-crosslinked purified fibrin. Thromb Diath Haemorrh. 34:1975;584-585.
274. 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. J Clin Invest. 69:1982;536-542.
275. 2-plasmin inhibitor. Blood. 66:1985;157-160.
276. 2-antiplasmin on urokinase-induced fibrinolysis. Thromb Haemost. 80:1998;637-644.
277. 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis. Species differences Blood Coag Fibrinolysis. 4:1993;869-875.
278. Francis C.W., Marder V.J. Increased resistance to plasmic degradation of fibrin with highly crosslinked α-polymer chains formed at high factor XIII concentrations. Blood. 71:1988;1361-1365.
279. Francis C.W., Marder V.J. Rapid formation of large molecular weight α-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII. J Clin Invest. 80:1987;1459-1465.
280. McDonagh J., Fukue H. Determinants of substrate specificity for factor XIII. Sem Thromb Haemost. 22:1996;369-376.
281. Sakata Y., Mimuro J., Aoki N. Differential binding of plasminogen to crosslinked and non-crosslinked fibrin. Its significance in hemostatic defect in factor XIII deficiency Blood. 63:1984;1393-1401.
282. 2-antiplasmin to fibrin. Thromb Haemost. 68:1992;315-320.
283. 2-plasmin inhibitor crosslinked to fibrin. Thromb Haemost. 70:1993;376.
284. Hevessy Z., Haramura G., Boda Z., Udvardy M., Muszbek L. The role of platelet factor XIII in fibrin-alpha-2-antiplasmin crosslinking. Thromb Haemost. 75:1996;161-167.
285. Greenberg C.S., Shuman M.A. Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets. J Biol Chem. 259:1984;14721-14727.
286. Kreager J.A., Devine D.V., Greenberg C.S. Cytofluorometric identification of plasmin-sensitive factor XIIIa binding to platelets. Thromb Haemost. 60:1988;88-93.
287. Cox A.D., Devine D.V. Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa. Blood. 83:1994;1006-1016.
288. Devine D.V., Andestad G., Nugent D., Carter C.J. Platelet-associated factor XIII as a marker of platelet activation in patients with peripheral vascular disease. Arterioscler Thromb. 13:1993;857-862.
289. Rubens F.D., Perry D.W., Hatton M.W.C., Bishop P.D., Packham M.A., Kinlough-Rathbone R.L. Platelet accumulation on fibrin-coated polyethylene. Role of platelet activation and factor XIII Thromb Haemost. 73:1995;850-856.
290. Devine D.V., Bishop P.D. Platelet-associated factor XIII in platelet activation, adhesion and clot stabilization. Semin Thromb Haemost. 22:1966;409-413.
291. Hársfalvi J., Brosstad F., Muszbek L. Platelet adhesion and plasmin generation on immobilized and FXIII crosslinked fibrin(ogen). Fibrinolysis Proteolysis. 12(Suppl I):1998;48a.
292. Chung S.I., Lee S.Y., Uchino R., Carmassi F. Factors that control extravascular fibrinolysis. Semin Thromb Haemost. 22:1996;479-488.
293. Ádány R., Kappelmayer J., Berényi E., Szegedi A., Fábián E., Muszbek L. Factors of the extrinsic pathway of blood coagulation in tumor associated macrophages. Thromb Haemost. 62:1989;850-855.
294. Constantini V., Zacharski L.R. Fibrin and cancer. Thromb Haemost. 65:1993;406-414.
295. Dvorak H.F., Senger D.R., Dvorak A.M. Fibrin as a component of the tumor stroma. Origins and biological significance Cancer Metastasis Rev. 2:1983;41-73.
296. Ádány R., Szegedi A., Ablin R.J., Muszbek L. Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease. Thromb Haemost. 60:1988;293-297.
297. Muszbek L., Ádány R. Intratumoral fibrin stabilization. Nigam S.K., McBrien D.C.H., Slater T.F. Lipid peroxidation and cancer. 1988;339-349 Springer Verlag, Berlin.
298. Dvorak H.F., Harvey S., McDonagh J. Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas. Cancer Res. 44:1984;3348-3354.
299. Zacharski L.R., Brown F.E., Memoli W.A., Kisiel W., Kudryk B.J., Rousseau S.M., Hunt J.A., Dunwiddie C., Nutt A.M. Pathways of coagulation activation in situ in rheumatoid synovial tissue. Clin Immun Immunopathol. 63:1992;155-162.
300. Carmassi F., de Negri F., Morale M., Song K.Y., Chung S.I. Fibrin degradation in the synovial fluid of rheumatoid arthritis patients. A model for extravascular fibrinolysis Semin Thromb Haemost. 22:1996;489-496.
301. Chignier E., Baguet J., Dessapt B., Bellevile J., Descotes Y., Eloy R. Skin healing and fibrin stabilization factor blood levels in rabbit fetus. J Surg Res. 31:1981;415-432.
302. Marktl W., Rundas B. The effect of factor XIII on wound granulation in the rat. Thromb Diath Haemorrh. 32:1974;578-581.
303. Knoche H., Schmitt G. Autoradiographische Untersuchungen über den Einfluss des Factors XIII auf die Wundheilung im Tierexperiment. Arzn Forsch. 26:1976;547-551.
304. Gierhake F.W., Volkman W., Becker W., Schwarz H., Schwick J.C. Factor XIII concentration and wound healing. German Med Month. 15:1970;721-725.
305. Gierhake F.W., Papastavrou N., Zimmermann K., Bohn H., Schwick J.C. The prophylaxis of postoperative disturbances of wound healing with Factor XIII substitution (result of a double-blind study). Deutsch Med Wschr. 99:1974;1004-1009.
306. Mishima Y., Nagao F., Ishibiki K., Matsuba M., Nakamura N. Faktor XIII in der Behandlung postoperative-theratierefrakturer Wundheilungsstörungen. Chirurg. 55:1984;803-808.
307. Wozniak G., Dappel F., Alemany J. Factor XIII in ulcerative leg disease. Background and preliminary clinical results Semin Thromb Hemost. 22:1996;445-450.
308. Isogai N., Ueda Y., Kurozumi N., Kamiishi H. Wound healing at the site of microvascular anastomosis. Fibrin-stabilizing factor XIII administration and its effects Microsurgery. 11:1990;40-46.
309. Claes L., Burri C., Gerngross H., Mutschler W. Die Beschlennigung der Frakturheilung durch Faktor XIII. Helv Chir Acta. 51:1984;209-212.
310. Claes L., Burri C., Gerngross H. Mutschler W. Bone healing stimulated by plasma FXIII, osteotomy experiments in sheep. Acta Orthop Scand. 56:1985;577-582.
311. Kienapfel H., Swain R., Hettel A., Wilke A., Koller M., Griss P. Recombinant and nonrecombinant factor XIII and its effect on bone ingrowth and strength of fixation. Arch Orthop Trauma Surg. 116:1997;239-243.
312. Gerngross H., Claes L. Successful treatment of pseudoarthrosis with human placental factor XIII concentrate. McDonagh J., Seitz R., Egbring R. Factor XIII. Second international conference:1993;271 Schattauer, Stuttgart.
313. Beck E., Duckert F., Ernst M. The influence of fibrin stabilizing factor on the growth of fibroblasts in vitro and wound healing. Thromb Diath Haemorrh. 6:1961;485-491.
314. Ueyama M., Urayama T. The role of factor XIII in fibroblast proliferation. Jpn J Exp Med. 48:1978;135-142.
315. Bruhn H.D., Pohl J. Growth regulation of fibroblasts by thrombin, factor XIII and fibronectin. Klin Wochenscr. 59:1981;145-146.
316. Paye M., Nusgens B.V., Lapière C.M. Factor XIII of blood coagulation modulates collagen biosynthesis by fibroblasts in vitro. Haemostasis. 19:1989;274-283.
317. Barry E.L.R., Mosher F.D. Binding and degradation of blood coagulation factor XIII by cultured fibroblasts. J Biol Chem. 265:1990;9302-9307.
318. Bruhn HD, Bernmeier R, Broers H, Pohl J. Regulation der Fibroblasten- und Endothelzellenproliferation durch Thrombin, Factor XIII und Fibronectin. In: Verhandlungsbericht der 25. Tagung der deutschen Arbeitgemeinschaft für Blutgerinnungsforschung. Stuttgart: Schattauer; 1981. p. 257-65.
319. Bruhn H.D. Growth regulation of vessel wall cells and of tumor cells by thrombin, factor XIII and fibronectin. Thromb Haemost. 46:1981;762.
320. Bruhn H.D., Zurborn K.H. Influences of clotting factors (thrombin, factor XIII) and of fibronectin on the growth of tumor cells and leukemic cells in vitro. Blut. 46:1983;85-88.
321. Ádány R., Fodor F., Molnár P., Ablin R.J., Muszbek L. Increased density of histiocytes in uterine leiomyomas. Int J Gynec Path. 9:1990;137-144.
322. Bergsen M., Weller M., Heimann K., Wiedemann P. Nachweis von Gerinnungsfaktor XIII im Glaskörper und periretinalen Membranen bei proliferativen Netzhauterkrankungen. Forschr Ophtalmol. 87:1990;279-282.
323. Weller M., Bergsen M., Heinmann K., Wiedemann P. Blood coagulation factor XIII contributes to the development of traction retinal detachment. Acta Ophtalmol. 68:1990;246-252.
324. Kang Y., Hashimoto N., Kikuchi H., Yamazoe N., Hazama F. Effects of blood coagulation factor XIII on the development of experimental cerebral aneurysms in rats. J Neurosurg. 73:1990;242-247.
325. Kasai S., Kunimoto T., Nitta K. Cross-linking of fibrin by activated factor XIII stimulates attachment, morphological changes and proliferation of fibroblasts. Biomed Res. 4:1983;155-160.
326. Naito M., Nomura H., Iguchi A., Thompson W.D., Smith E.B. Effect of crosslinking by factor XIII on the migration of vascular smooth muscle cells into fibrin gels. Thromb Res. 90:1998;111-116.
327. Grinnel F., Feld M., Minter D. Fibroblast adhesion to fibrinogen and fibrin substrates. Requirement for cold insoluble globulin (plasma fibronectin) Cell. 19:1980;517-525.
328. Corbett S.A., Lee L., Wilson C.L., Schwarzbauer J.E. Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin-fibrin matrix. J Biol Chem. 272:1997;24999-25005.
329. Lanir N., Ciano P.S., Van de Water L., McDonagh J., Dvorak A.M., Dvorak H.F. Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration. J Immunol. 140:1988;2340-2349.
330. Paye M., Lapière C.M. The lack of attachment of transformed embryonic lung epithelial cells to collagen I is corrected by fibronectin and factor XIII. J Cell Sci. 86:1986;95-107.
331. Ueki S., Tagaki J., Saito Y. Dual functions of transglutaminase in novel cell adhesion. J Cell Sci. 109:1996;2727-2735.
332. Leibovich S.J., Ross R. The role of macrophages in wound repair. A study with hydrocortisone and antimacrophage serum. Amer J Pathol. 78:1975;71-100.
333. Glynn LE. Tissue repair and regeneration. New York: Raven Press, 1985.
334. Okamoto M., Yamamoto T., Matsubara S., Kukita I., Takeya M., Miyauchi Y., Kambara T. Factor XIII-dependent generation of 5th complement component(C5)-derived monocyte chemotactic factor coinciding with plasma clotting. Biochim Biophys Acta. 1138:1992;53-61.
335. Mikkola H., Muszbek L., Laiho E., Syrjälä M., Hämäläinen E., Haramura G., Salmi T., Peltonen L., Palotie A. Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency. A splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA Blood. 89:1997;1279-1287.
336. Muszbek L., Ádány R., Kávai M., Boda Z., Lopaciuk S. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit A antigen and transglutaminase activity. Thromb Haemost. 59:1988;231-235.
337. Boda Z., Pfliegler G., Muszbek L., Tóth A., Ádány R., Hársfalvi J., Papp Z., Tornai I., Rák K. Congenital factor XIII deficiency with multiple benign breast tumors and successful pregnancy with substitutive therapy. Haemostasis. 19:1989;348-352.
338. Fisher S., Rikover M., Naor S. Factor 13 deficiency with severe hemorrhagic diathesis. Blood. 28:1966;34-39.
339. Rodeghiero F., Castaman G.C., Di Bona E., Ruggeri M., Dini E. Successful pregnancy in a women with congenital factor XIII deficiency. Blut. 55:1987;45-48.
340. Kobayashi T., Terao T., Kojima T., Takamatsu J., Kamiya T., Saito H. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. Gynec Obstet Invest. 29:1990;235-238.
341. Saito M., Asakura H., Yoshida T., Ito K., Okafuji K., Yoshida T., Matsuda T. A familial factor XIII subunit B deficiency. Br J Haematol. 74:1990;290-294.
342. Halkiel T., Magnusson S. Contact activation of blood coagulation is inhibited by plasma factor XIII b-chain. Thromb Res. 51:1988;313-324.
343. Kasahara K., Takagi J., Sekiya F., Inada Y., Saito Y. "A" subunit of factor XIII is present on bovine platelet membrane and mediates collagen-induced platelet activation. Thromb Res. 50:1988;253-263.
344. Saito Y., Imada T., Takagi J., Kikuchi T., Inada Y. Platelet factor XIII. The collagen receptor? J Biol Chem. 261:1986;1355-1358.
345. Aihara M., Sawada Y., Takami H., Kariya K., Kudo I., Kimura A., Yoshida Y. Factor XIII is not involved in human platelet-collagen interaction. Tohoku J Exp Med. 159:1989;37-44.
346. Ozsoylu S., Hicsonmez G. Platelet aggregation in congenital factor XIII deficiency. Acta Haematol. 56:1976;314-317.
347. Sixma J.J., Van den Berg A., Schiphorst M., Geuze H.J., McDonagh J. Immunocytochemical localization of albumin and factor XIII in thin cryo sections of human blood platelets. Thromb Haemost. 51:1984;388-391.
348. Joist J.H., Niewiarowski S. Retention of platelet fibrin stabilizing factor during the platelet release reaction and clot retraction. Thromb Diath Haemorrh. 29:1973;679-683.
349. Holme P.A., Brosstadt F., Solum N.O. The difference between platelet and plasma FXIII used to study the mechanism of platelet microvesicle formation. Thromb Haemost. 70:1993;681-686.
350. Conkling P.R., Achyuthan K.E., Greenberg C.S., Newcomb T.F., Weinberg J.B. Human mononuclear phagocyte transglutaminase activity cross-links fibrin. Thromb Res. 55:1989;57-68.
351. Lajemi M., Demignot S., Adolphe M. Detection and characterization, using Fluoreceincadaverine, of amine acceptor protein substrates accessible to active transglutaminase expressed by rabbit articular chondrocytes. Histochem J. 30:1998;499-508.
352. Cohen I., Lim C.T., Kahn D.R., Glaser T., Gerrard J.M., White J.G. Disulfide-linked and transglutaminase-catalyzed protein assemblies in platelets. Blood. 66:1985;143-151.
353. Rao K.M.K., Newcomb T.F. Clot retraction in a factor XIII free system. Scand J Haematol. 24:1980;142-148.
354. Zhu Y., Tass L., Lane W., Mendelsohn M.E. Specific binding of the transglutaminase, platelet factor XIII, to HSP27. J Biol Chem. 269:1994;22379-22384.
355. Mendelsohn M.E., Zhu Y., O'Neill S. The 29-kDa proteins phosphorylated in thrombin-activated human platelets are forms of the estrogen receptor related 27-kDa heat shock protein. Proc Natl Acad Sci USA. 88:1991;11212-11216.
356. Zhu Y., O'Neill S., Mendelsohn M.E. HSP27, a thrombin-activated phosphoprotein, translocates to the cytoskeleton following human platelet activation. Circulation. 86(Suppl I):1992;739a.
357. Muszbek L., Ádány R., Lopaciuk S., Kávai M. Possible role of factor XIII subunit a in phagocytosis by monocytes. Haematol Rev. 1:1986;120a.
358. Kávai M., Ádány R., Pásti G., Surányi P., Szûcs G., Muszbek L., Boján F., Szegedi G. Marker profile, enzyme activity, and function of a human myelomonocytic leukemia cell line. Cellular Immunol. 139:1992;531-540.